| | Business Summary | | Ventana
Medical
Systems,
Inc.
develops,
manufactures
and
markets
instruments
and
consumables
that
are
used
to
automate
diagnostic
and
drug
discovery
procedures
in
clinical
histology
laboratories
and
drug
discovery
laboratories
worldwide.
The
Company
has
six
subsidiaries,
including
Ventana
Medical
Systems
GmbH,
Ventana
Medical
Systems
Japan
K.K.,
Ventana
Medical
Systems,
Pty.
Ltd.,
Ventana
Medical
Systems
S.A.,
BioTek
Solutions
Inc.
and
BioTechnology
Tools
Inc.
The
Company
markets
four
product
lines:
tissue
processors,
immunohistochemistry
staining
instruments,
Special
Stains
instruments
and
in
situ
hybridization
staining
instruments.
All
of
these
instruments
use
consumables,
such
as
reagents,
barcode
labels
and
wicking
pads,
many
of
which
the
Company
sells. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Ventana
Medical
Systems
develops,
manufactures,
and
markets
instruments
and
reagents
that
automate
diagnostic
procedures
used
for
the
molecular
analysis
of
cells.
For
the
six
months
ended
6/30/01,
total
revenues
increased
13%
to
$40.6
million.
Net
loss
before
accouning
change
decreased
95%
to
$1.1
million.
Revenues
reflect
the
growth
in
the
underlying
install
base.
Lower
loss
reflects
improved
gross
margins
and
the
absence
of
non-recurring
charges. | | More
from
Market Guide: Significant
Developments |
| | | | FY1999 Pay | |
| Jack Schuler, 59
Chairman | -- | Christopher Gleeson, 50
Pres,
CEO, Director | $194K | John Patience, 52
Vice
Chairman | -- | Nick Malden, 43
CFO | -- | Tamaki Tateiwa, 60
Pres
of Ventana Medical Systems Japan K.K | 175K | | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/v/vmsi.gif)